Cited by 589Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 57 of the 62 references it cites were found in a registry or an index.

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

Open access

DeUgarte, Catherine Marin, Bartolucci, Alfred A., Azziz, Ricardo·2005·Fertility and Sterility

DOI 10.1016/j.fertnstert.2004.11.070

Open this paper in CoChat — free account

Abstract

Objective To determine the prevalence of insulin resistance (IR) in a large population of patients with the polycystic ovary syndrome (PCOS).Design Prospective, case-control.Setting University medical center.Patient(s) Two hundred seventy-one PCOS patients and 260 eumenorrheic, non-hirsute, control women.Intervention(s) History and physical examination and blood sampling.Main outcome measure(s) Total T, free T, DHEAS, sex hormone-binding globulin, and fasting glucose and insulin levels; homeostatic model assessment values for IR (HOMA-IR) and percent beta-cell function (HOMA-%beta-cell).Result(s) Patients with PCOS and controls differed significantly in all parameters studied, except fasting glucose. Because the HOMA-IR and HOMA-%beta-cell values were variably associated with race, age, and body mass index, the HOMA-IR and HOMA-%beta-cell values were then adjusted for these cofounders. After adjustment, 64.4% of PCOS patients were noted to be insulin resistant, and 2.6% had beta-cell dysfunction. Compared with PCOS patients without IR (n = 96), patients with IR (n = 174) were more obese and had higher beta-cell function.Conclusion(s) In patients with PCOS, the prevalence of IR was 64% according to the HOMA-IR measurement, after adjustment. Patients with IR were more clinically affected. Although IR is a common abnormality in PCOS, it does not seem to be a universal feature.

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2004.11.070

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Self-citation
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Lévy, J., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,023
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Self-citation
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
Asunción, M., Calvo, R. M., Millán, J. L. S., Sancho, J., Ávila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,328

Flagged first, then by citations

Show all 62 references

5 of the 62 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 586

Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome
Brennan, K., Huang, A., & Azziz, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.101 · Cited by 61
Self-citation
Medical management of metabolic dysfunction in PCOS
Dulęba, A. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.11.014 · Cited by 60
Metabolic syndrome, diet and exercise
Sousa, S. M. C. D., & Norman, R. J. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.01.006 · Cited by 60
Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis
Tehrani, F. R., Behboudi‐Gandevani, S., Yarandi, R. B., Naz, M. S. G., & Carmina, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1859474 · Cited by 65
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome
Goodarzi, M. O., Louwers, Y. V., Taylor, K. D., Jones, M. R., Cui, J., Kwon, S., Chen, Y. I., Guo, X., Stolk, L., Uitterlinden, A. G., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.015 · Cited by 59
Self-citation
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus
Zhang, Y., Sun, X., Sun, X., Meng, F., Hu, M., Li, X., Li, W., Wu, X., Brännström, M., Shao, R., et al. (2016) · Scientific Reports · doi:10.1038/srep30679 · Cited by 59
The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial
Samimi, M., Mehrizi, M. Z., Foroozanfard, F., Akbari, H., Jamilian, M., Ahmadi, S., & Asemi, Z. (2016) · Clinical Endocrinology · doi:10.1111/cen.13288 · Cited by 64
Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression
Qi, X., Zhang, B., Zhao, Y., Li, R., Chang, H., Pang, Y., & Qiao, J. (2017) · Endocrinology · doi:10.1210/en.2017-00039 · Cited by 59
Inositols’ Importance in the Improvement of the Endocrine–Metabolic Profile in PCOS
Wojciechowska, A., Osowski, A., Jóźwik, M., Górecki, R. J., Rynkiewicz, A., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225787 · Cited by 64
Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome
Thomson, R. L., Buckley, J. D., Moran, L., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02177.x · Cited by 60
Elevated androgen levels induce hyperinsulinemia through increase in Ins1 transcription in pancreatic beta cells in female rats†
Mishra, J. S., More, A. S., & Kumar, S. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy017 · Cited by 61
Relation of nutrients and hormones in polycystic ovary syndrome
Kasim-Karakas, S. E., Cunningham, W., & Tsodikov, A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.688 · Cited by 57
Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria
Alebić, M. Š., Bulum, T., Stojanović, N., & Duvnjak, L. S. (2014) · Endocrine · doi:10.1007/s12020-014-0182-5 · Cited by 56
Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats.
Mohammadi, S., Karimzadeh, L., Hojati, V., Ghorbani, A. G., & Nabiuni, M. (2017) · PubMed Central · doi:10.22074/cellj.2017.4415 · Cited by 56
Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
Dey, R., Bhattacharya, K., Basak, A. K., Paul, N., Bandyopadhyay, R., Chaudhuri, G. R., Purkait, M. P., Bhattacharjee, A., Bose, C., Shukla, N., et al. (2023) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00158-2 · Cited by 62
How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models
Lewandowski, K. C., Skowrońska‐Jóźwiak, E., Łukasiak, K., Gałuszko, K., Dukowicz, A., Cedro, M., & Lewiñski, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.82672 · Cited by 55
Elevated Chemerin Induces Insulin Resistance in Human Granulosa-Lutein Cells from Polycystic Ovary Syndrome Patients
Li, X., Zhu, Q., Wang, W., Qi, J., He, Y., Wang, Y., Lu, Y., Wu, H., Ding, Y., & Sun, Y. W. (2018) · The FASEB Journal · doi:10.1096/fj.201802829r · Cited by 54
Action of Metformin on the Insulin-Signaling Pathway and on Glucose Transport in Human Granulosa Cells
Rice, S., Pellatt, L. J., Bryan, S., Whitehead, S. A., & Mason, H. D. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2060 · Cited by 54
Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial
Liu, C., Feng, G., Huang, W., Wang, Q., Yang, S., Tan, J., Fu, J., & Liu, D. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1332174 · Cited by 59
Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women
Martins, W. P., Santana, L. F., Nastri, C. O., Ferriani, F. A., de Sá, M. F. S., & dos Reis, R. M. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.038 · Cited by 54
The role of the endogenous opioid system in polycystic ovary syndrome
Eyvazzadeh, A. D., Pennington, K. P., Pop‐Busui, R., Sowers, M., Zubieta, J., & Smith, Y. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.012 · Cited by 54
Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: A randomized study
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., Wiltgen, D., Cristina Matos, M., & Spritzer, P. M. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.564686 · Cited by 52
Therapeutic Effects and Mechanisms of Herbal Medicines for Treating Polycystic Ovary Syndrome: A Review
Kwon, C.-Y., Cho, I.-H., & Park, K. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01192 · Cited by 52
Flow‐mediated dilatation in overweight and obese women with polycystic ovary syndrome
Brinkworth, G. D., Noakes, M., Moran, L., Norman, R. J., & Clifton, P. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01090.x · Cited by 52
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china
Huang, J., Ni, R., Chen, X., Huang, L., Mo, Y., & Yang, D. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-142 · Cited by 52
Is There a Bidirectional Association between Polycystic Ovarian Syndrome and Periodontitis? A Systematic Review and Meta-analysis
Machado, V., Escalda, C., Proença, L., Mendes, J. J., & Botelho, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061961 · Cited by 52
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study
Ramezani Tehrani, F., Minooee, S., & Azizi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0094 · Cited by 51
The neuroendocrine genesis of polycystic ovary syndrome: A role for arcuate nucleus GABA neurons
Moore, A. M., & Campbell, R. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.002 · Cited by 54
The Contribution of Endogenous and Exogenous Factors to Male Alopecia
Gatherwright, J. R., Liu, M. T., Amirlak, B., Gliniak, C. M., Totonchi, A. S., & Guyuron, B. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182865ca9 · Cited by 51
Putative role for insulin resistance in depression risk in polycystic ovary syndrome
Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.019 · Cited by 51
31. Polycystic ovary syndrome and the metabolic syndrome
Hunter, T., & Hart, R. J. (2014) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-767-7.031 · Cited by 51
Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver
Zhang, Y., Meng, F., Sun, X., Sun, X., Hu, M., Cui, P., Vestin, E., Li, X., Li, W., Wu, X., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24477 · Cited by 52
Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome.
Khani, B., Mehrabian, F., Khalesi, E., & Eshraghi, A. (2011) · Europe PMC (PubMed Central) · Cited by 50
Endocrine correlates of polycystic ovary syndrome in Pakistani women.
Akram, M., & Roohi, N. (2015) · PubMed · Cited by 50
Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation
Malin, S. K., Kirwan, J. P., Sia, C. L., & González, F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2014 · Cited by 49
Metabolomics and correlation network analysis of follicular fluid reveals associations between l ‐tryptophan, l ‐tyrosine and polycystic ovary syndrome
Hou, E., Zhao, Y., Hang, J., & Qiao, J. (2020) · Biomedical Chromatography · doi:10.1002/bmc.4993 · Cited by 47
Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Varma, S. H., Tirupati, S., Pradeep, T. V. S., Sarathi, V., & Kumar, D. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.12.020 · Cited by 47
Obese and non-obese polycystic ovarian syndrome: Comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene
Gainder, S., Sachdeva, G., Suri, V., Sachdeva, N. K., & Chopra, S. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_637_18 · Cited by 47
Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance
Castellano, C., Baillargeon, J., Nugent, S., Tremblay, S., Fortier, M., Imbeault, H., Duval, J. M., & Cunnane, S. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144116 · Cited by 47
Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome
Markou, Α., Androulakis, I. I., Mourmouris, C. N., Tsikkini, A., Samara, C., Sougioultzis, S., Piaditis, G. P., & Kaltsas, G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.008 · Cited by 45
Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function
Ezeh, U. I., Chen, I. Y.-D., Chen, Y., & Azziz, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa235 · Cited by 46
Self-citation
Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study
Yang, P.-K., Chou, C.-H., Chang, C., Chen, S., Ho, H., & Chen, M. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00629-5 · Cited by 44
Androgens as double-edged swords: Induction and suppression of follicular development
Pan, J., Zhang, J., Ke, Z.-H., Wang, F., Barry, J. A., Hardiman, P., & Qu, F. (2015) · HORMONES · doi:10.14310/horm.2002.1580 · Cited by 41
Association between Th1/Th2 immune imbalance and obesity in women with or without polycystic ovary syndrome
Gong, P., Shi, B., Wang, J., Cao, P., Diao, Z., Wang, Y., Hu, Y., & Li, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428301 · Cited by 43
The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome
Zhang, L., Fang, X., Li, L., Liu, R., Zhang, C., Liu, H., Tan, M., & Yang, G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0902-4 · Cited by 43
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome
Fulghesu, A. M., Angioni, S. L., Portoghese, E., Milano, F., Batetta, B., Paoletti, A. M., & Melis, G. B. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.024 · Cited by 43
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors
Shi, Y., Cui, Y., Sun, X., Ma, G., Ma, Z.-X., Gao, Q. F., & Chen, Z. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.011 · Cited by 42
Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference
Bruno, R. V., de Ávila, M. A. P., Neves, F. B., Nardi, A. E., Crespo, C. M. S., & Sobrinho, A. T. C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.133 · Cited by 42
Effect of High Fat Diet on Disease Development of Polycystic Ovary Syndrome and Lifestyle Intervention Strategies
Han, Y., Wu, H., Sun, S., Zhao, R., Deng, Y., Zeng, S., & Chen, J. (2023) · Nutrients · doi:10.3390/nu15092230 · Cited by 55
Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome
Feldman, R., O’Neill, K. E., Butts, S. F., & Dokras, A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.009 · Cited by 41
Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development
Abruzzese, G. A., Silva, A. F., Velázquez, M. E., Ferrer, M., & Motta, A. B. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1558 · Cited by 43
Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40
Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
Advani, K., Batra, M., Tajpuriya, S., Gupta, R., Saraswat, A., Nagar, H. D., Makwana, L., Kshirsagar, S., Kaul, P., Ghosh, A. K., et al. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1604644 · Cited by 42
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome
Antoine, H. J., Pall, M., Trader, B. C., Chen, Y. I., Azziz, R., & Goodarzi, M. O. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.10.006 · Cited by 40
Self-citation
Roles of estrogen and its receptors in polycystic ovary syndrome
Xu, Y., Zhang, Z., Wang, R., Xue, S., Ying, Q., & Jin, L. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1395331 · Cited by 38
Prevalence and degree of insulin resistance in Chinese Han women with PCOS: Results from euglycemic‐hyperinsulinemic clamps
Li, W., Chen, Q., Xie, Y., Hu, J., Yang, S., & Lin, M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13860 · Cited by 39
Role of Vitamin B12 and Folate in Metabolic Syndrome
Ashok, T., Puttam, H., Tarnate, V. C. A., Jhaveri, S., Avanthika, C., Treviño, A. G. T., Sandeep, S. L., & Ahmed, N. (2021) · Cureus · doi:10.7759/cureus.18521 · Cited by 43
Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 44
Insulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum
Prosperi, S., & Chiarelli, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1669716 · Cited by 58
Effects of Exenatide on Metabolie Changes, Sexual Hormones, Inflammatory Cytokines, Adipokines, and Weight Change in a DHEA-Treated Rat Model
Sun, L., Cheng, J., Jin, L., Bi, Y., Feng, W., Li, P., Shen, S., & Zhu, D. (2016) · Reproductive Sciences · doi:10.1177/1933719116635278 · Cited by 37
The interactions of CAP and LYN with the insulin signaling transducer CBL play an important role in polycystic ovary syndrome
Shen, H., Xu, X. L., Fu, Z., Xu, C., & Wang, Y. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155164 · Cited by 37
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome
Targher, G., Solagna, E., Tosi, F., Castello, R., Spiazzi, G., Zoppini, G., Muggeo, M., Day, C., & Moghetti, P. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345743 · Cited by 37
The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
Tabrizi, F. P. F., Farhangi, M. A., Vaezi, M., & Hemmati, S. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00601-4 · Cited by 41
The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome
Santos, A., Soares, N. P., Costa, E. C., de Sá, J. C. F., Azevedo, G. D., & Lemos, T. M. A. M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.976546 · Cited by 36
Proteomics and polycystic ovary syndrome
Insenser, M. R., & Escobar-Morreale, H. F. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.837665 · Cited by 35
Status of clomiphene citrate and metformin for infertility in PCOS
Misso, M. L., Teede, H. J., Hart, R. J., Wong, J., Rombauts, L. J. F., Melder, A., Norman, R. J., & Costello, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.07.001 · Cited by 37
The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome
Petríková, J., Lazúrová, I., Dravecká, I., Vrbíková, J., Kozáková, D., Figurová, J., Vaczy, Z., & Rosocha, J. (2014) · Biomedical Papers · doi:10.5507/bp.2014.062 · Cited by 36
The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome
Karamali, M., Ashrafi, M., Razavi, M., Jamilian, M., Akbari, M., & Asemi, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-104530 · Cited by 34
High Fasting Insulin Levels and Insulin Resistance May Be Linked to Idiopathic Recurrent Pregnancy Loss: A Case-Control Study
Ispasoiu, C.-A., Chicea, R., Stamatian, F. V., & Ispasoiu, F. (2013) · International Journal of Endocrinology · doi:10.1155/2013/576926 · Cited by 35
Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
Vrbíková, J., Dvorakova, K., Grimmichová, T., Hill, M., Stanická, S., Cibula, D., Bendlová, B., Stárka, L., & Vondra, K. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.113 · Cited by 35
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3
Chang, W., Goodarzi, M. O., Williams, H., Magoffin, D. A., Pall, M., & Azziz, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.10.025 · Cited by 35
Self-citation
Diagnostic and therapeutic use of oral micronized progesterone in endocrinology
Memi, E., Pavli, P., Papagianni, M., Vrachnis, N., & Mastorakos, G. P. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09882-0 · Cited by 39
Metabolic Aspects of Bariatric Surgery
Folli, F. B., Pontiroli, A. E., & Schwesinger, W. H. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.01.005 · Cited by 33
The Effect of Exercise on Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Breyley-Smith, A., Mousa, A., Teede, H. J., Johnson, N. A., & Sabag, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031386 · Cited by 34
The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS.
Qu, Z., Zhu, Y., Jiang, J., Shi, Y., & Chen, Z. (2013) · Europe PMC (PubMed Central) · Cited by 34
The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study
Hosseinpanah, F., Barzin, M., Tehrani, F. R., & Azizi, F. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04113.x · Cited by 34
Computational Methods Are Significant Determinants of the Associations and Definitions of Insulin Resistance Using the Homeostasis Model Assessment in Women of Reproductive Age
Safar, F. H., Mojiminiyi, O. A., Al‐Rumaih, H., & Diejomaoh, M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152025 · Cited by 34
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
Oral, B., Ceyhan, B. M., Dilek, M., Alanoğlu, G., & Sütçü, R. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802549874 · Cited by 34
Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?
Kong, A. P. S., Luk, A. O. Y., & Chan, J. C. N. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.003 · Cited by 36
Assessment of anogenital distance as a diagnostic tool in polycystic ovary syndrome
Peñalver, A. I. H., Sánchez-Ferrer, M. L., Mendiola, J., Adoamnei, E., Prieto‐Sánchez, M. T., Corbalán‐Biyang, S., Carmona‐Barnosi, A., Nieto, A., & Torres-Cantero, A. M. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.08.020 · Cited by 32
Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values
Kim, J., Hwang, K. R., Oh, S. H., Chae, S. J., Yoon, S. H., & Choi, Y. M. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.06.035 · Cited by 34
Weight management strategies for patients with PCOS: current perspectives
Ozgen Saydam, B., & Yildiz, B. O. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1896966 · Cited by 33
Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973–1991
Mumm, H., Kamper‐Jørgensen, M., Andersen, A. N., Glintborg, D., & Andersen, M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.11.004 · Cited by 35
Aberrant elevation of GDF8 impairs granulosa cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS
Bai, L., Wang, W., Yu, X., Wang, S., Wan, S., & Zhu, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.005 · Cited by 33
The Contribution of Endogenous and Exogenous Factors to Female Alopecia
Gatherwright, J. R., Liu, M. T., Gliniak, C. M., Totonchi, A. S., & Guyuron, B. (2012) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31826d104f · Cited by 32
Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation
Marino, J. S., Iler, J., Dowling, A. R., Chua, S. C., Brüning, J. C., Coppari, R., & Hill, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048643 · Cited by 31
The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.
Zheng, J., Shan, P. F., & Gu, W. (2013) · PubMed · doi:10.3275/8932 · Cited by 31
Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review
Bhaskar, L. V., Thangavelu, M., & Rani, G. U. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0030-1 · Cited by 32
Enhanced insulin sensitivity and acute regulation of metabolic genes and signaling pathways after a single electrical or manual acupuncture session in female insulin-resistant rats
Benrick, A., Maliqueo, M. A., Johansson, J., Sun, M., Wu, X., Mannerås-Holm, L., & Stener‐Victorin, E. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0645-4 · Cited by 31
Common Variants in the Sex Hormone-Binding Globulin (SHBG) Gene Influence SHBG Levels in Women with Polycystic Ovary Syndrome
Abu‐Hijleh, T. M., Gammoh, E., Al-Busaidi, A. S., Malalla, Z. H. A., Madan, S., Mahmood, N., & Almawi, W. Y. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000441570 · Cited by 31
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E., & Christakou, C. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_4 · Cited by 32
The Diabetes-Cardiovascular Connection in Women: Understanding the Known Risks, Outcomes, and Implications for Care
Broni, E. K., Ndumele, C. E., Echouffo-Tcheugui, J. B., Kalyani, R. R., Bennett, W. L., & Michos, E. D. (2022) · Current Diabetes Reports · doi:10.1007/s11892-021-01444-x · Cited by 32
The effects of selenium supplementation on glycemic control, serum lipoproteins and biomarkers of oxidative stress in infertile women diagnosed with polycystic ovary syndrome undergoing in vitro fertilization: A randomized, double-blind, placebo-controlled trial
Modarres, S. Z., Asemi, Z., & Heidar, Z. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.07.017 · Cited by 35
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study
Elkind-Hirsch, K. E., Paterson, M. S., Seidemann, E. L., & Gutowski, H. C. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.023 · Cited by 34
Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
Ganie, M. A., Dhingra, A., Nisar, S., Sreenivas, V., Shah, Z. A., Rashid, A., Masoodi, S. R., & Gupta, N. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.09.005 · Cited by 30
Metformin
Tan, M. H., Alquraini, H., Mizokami‐Stout, K., & MacEachern, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.008 · Cited by 33
Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple‐blind randomized clinical trial
Jabarpour, M., Aleyasin, A., Nashtaei, M. S., & Amidi, F. (2023) · Phytotherapy Research · doi:10.1002/ptr.8037 · Cited by 30
Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome
Huang, R., Zheng, J., Li, S., Tao, T., Ma, J., & Liu, W. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12612 · Cited by 30

Authors: DeUgarte, C. M., Bartolucci, A. A., & Azziz, R.
Affiliations: Cedars-Sinai Medical Center (US)
University of Alabama at Birmingham (US)
Corresponding author: Azziz, Ricardo
ORCID: Bartolucci, Alfred A.
Azziz, Ricardo
Venue: Fertility and Sterility
Publisher: Elsevier BV
Published: 2005-05
Volume: 83
Issue: 5
Pages: 1454-1460
ISSN: 0015-0282 (ISSN-L)
DOI: 10.1016/j.fertnstert.2004.11.070
OpenAlex: W2117559317
Cited by: 589
References: 62
Citations by year: 2026: 14 · 2025: 23 · 2024: 24 · 2023: 30 · 2022: 41 · 2021: 32 · 2020: 33 · 2019: 33 · 2018: 23 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 33 · 2013: 48 · 2012: 21
FWCI: 23.24
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 6235 d)
Locations: Fertility and Sterility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, insulin resistance, HOMA-IR, beta-cell function, prevalence, obesity, sex hormones, insulin secretion
MeSH terms: Adult, Female, Homeostasis, Humans, Insulin Resistance, Middle Aged, Polycystic Ovary Syndrome, Prospective Studies, Prevalence, Chi-Square Distribution, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks